What is Osimertinib used for?

Osimertinib (previously known as mereletinib or AZD9291 is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor drug used to treat non-small-cell lung carcinomas with a specific mutation. The drug was fully approved as a cancer treatment in 2017 by both the Food and Drug Administration and the European Commission.
Osimertinib is used to treat locally advanced or metastatic non-small-cell lung cancer (NSCLC), if the cancer cells are positive for the T790M mutation in the gene coding for EGFR. The T790M mutation may be de novo or acquired following first-line treatment with other tyrosine kinase inhibitors (TKIs), such as gefitinib and afatinib.
Source Content : wikipedia

For procurement of Osimertinib brands in India, sold by Indian Drug Manufacturer. Please contact at M: +91 9811747774 or Email Us

Get In Touch

Osimertinib suppliers & wholesalers in India

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients TAGRISSO (Osimertinib) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India.
For overseas patient TAGRISSO (Osimertinib) brands in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

Osimertinib Biosimilar approved and marketed in India is available as 80 mg and 40 mg tablets.